Pancreatic Cancer Research

ResearcherUniversity of Kansas Medical CenterActive in the last 2 years

R. McKinnon Walsh

Verified by NIH RePORTER profile ID (good confidence, 0.85), identity_conf@1As of 6 November 2026

Matched on NIH RePORTER profile ID 77879620. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
1
Labs led
0
Collaborators
12
Papers, trials and grants by year

2022: 2 papers · 2023: none · 2024: 1 grant · 2025: 3 papers

Papers 5

  1. DUSP6 is upregulated in metastasis and influences migration and metabolism in pancreatic cancer cells. First author DOI 10.1038/s41598-025-12967-8↗
  2. Depletion of tumor-derived CXCL5 improves T cell infiltration and anti-PD-1 therapy response in an obese model of pancreatic cancer. Co-author DOI 10.1136/jitc-2024-010057↗
  3. Combined Omipalisib and MAPK Inhibition Suppress PDAC Growth. Co-author DOI 10.3390/cancers17071152↗
  4. Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells. Co-author DOI 10.1038/s41419-022-04572-8↗
  5. Correction: Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells. Co-author DOI 10.1038/s41419-022-04615-0↗

Grants 1

  1. Investigating the role of SHP2-PLCG1 interaction in PDAC calcium signaling and metabolism F31CA281118↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bailey A. Bye · 5 shared papers, 2022–2025 · strength 1.03
  2. Michael Nathan VanSaun · 5 shared papers, 2022–2025 · strength 1.03
  3. Appolinaire A. Olou · 4 shared papers, 2022–2025 · strength 0.80
  4. Mariana T. Ruckert · 4 shared papers, 2022–2025 · strength 0.76
  5. Sharon Manley · 2 shared papers, 2022 · strength 0.29
  6. Shrikant Anant · 2 shared papers, 2022 · strength 0.29
  7. Emily L. Lasse Opsahl · 1 shared paper, 2025 · strength 0.23
  8. Marina Pasca di Magliano · 1 shared paper, 2025 · strength 0.23
  9. Jiaqi Shi · 1 shared paper, 2025 · strength 0.23
  10. Vanessa S. Silveira · 1 shared paper, 2025 · strength 0.23
  11. Costas Andreas Lyssiotis · 1 shared paper, 2025 · strength 0.23
  12. Filip Bednar · 1 shared paper, 2025 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.